Press releases
* (R) = Regulatory press releases
Apr 20, 2023
(R) Cantargia has submitted a phase I clinical trial application for its second project, CAN10
Apr 19, 2023
(R) Cantargia presents anti-metastatic effects of nadunolimab in cancer models at AACR 2023
Apr 4, 2023
Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023
Mar 14, 2023
(R) Cantargia presents positive results for nadunolimab at AACR 2023 including new clinical data in pancreatic cancer
Mar 14, 2023
(R) Cantargia treats first triple-negative breast cancer patient in randomized phase II part of TRIFOUR trial
Feb 23, 2023
